- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05627700
AVL200 IOL for Treatment of Cataract and Presbyopia
July 26, 2023 updated by: Atia Vision
A Prospective, Open-label, Single-center Study of the Atia™ AVL200 Modular Intraocular Lens System for Treatment of Cataract and Presbyopia
This study is to evaluate the performance of the AVL200 IOL in terms of visual function improvement over a range of focal points.
Participants meeting eligibility criteria will undergo cataract surgery with implantation of the AVL200 intraocular lens (IOL), then be followed through 1 year postoperatively.
Postoperative assessments include safety and visual function.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Melissa Guerrero
- Phone Number: 408-560-3339
- Email: melissa@atiavision.com
Study Contact Backup
- Name: Preethi Thiagarajan, OD
- Email: preethi@atiavision.com
Study Locations
-
-
Tamal Nadu
-
Chennai, Tamal Nadu, India, 600018
- Recruiting
- Dr Agarwal's Eye Hospital
-
Contact:
- Study Coordinator
- Phone Number: 044 4300 8800
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Visually significant cataract
- Best corrected distance visual acuity between 20/40 and 20/200
- Potential distance visual acuity of 20/32 or better
- Corneal astigmatism ≤ 1.5 diopters
Exclusion Criteria:
- Use of medication that could affect accommodation
- Previous corneal surgery or significant corneal abnormalities
- Ocular pathology or degenerative disorder having potential to impair visual acuity
- Pupil abnormality
- Intraoperative cataract surgery complications that could affect IOL implantation or positioning
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: AVL200 IOL
The AVL200 is a modular fluid-filled, shape-changing intraocular lens (IOL) designed to restore visual function across a range of focal points
|
The AVL200 is an intraocular lens surgically implanted in the eye after cataract surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in monocular best corrected distance visual acuity
Time Frame: 3 months postoperative
|
Best-corrected distance visual acuity as measured using an early-treatment diabetic retinopathy study (ETDRS) eye chart
|
3 months postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in monocular distance-corrected near visual acuity
Time Frame: 3 months postoperative
|
Distance-corrected distance visual acuity as measured using an early-treatment diabetic retinopathy study (ETDRS) eye chart
|
3 months postoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ashvin Agarwal, MD, Dr. Agarwals Eye Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 25, 2022
Primary Completion (Estimated)
October 31, 2025
Study Completion (Estimated)
January 31, 2026
Study Registration Dates
First Submitted
November 16, 2022
First Submitted That Met QC Criteria
November 16, 2022
First Posted (Actual)
November 28, 2022
Study Record Updates
Last Update Posted (Actual)
July 28, 2023
Last Update Submitted That Met QC Criteria
July 26, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP100962
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingCataract ExtractionChina
Clinical Trials on AVL200 IOL
-
University of TriesteCompleted
-
Peking University Third HospitalPeople's Hospital of GuangxiRecruitingPresbyopia | Cataract SenileChina
-
Maastricht University Medical CenterAbbott Medical OpticsCompletedCataract | PresbyopiaNetherlands
-
Peking University Third HospitalUnknown
-
Cutting Edge SASNot yet recruiting
-
Carolina Eyecare Physicians, LLCScience in VisionRecruiting
-
Carl Zeiss Meditec AGCompleted
-
Enrique Ordiñaga-Monreal, OD, MScUnknownAstigmatism | Visual Acuity | IOL | Cataract AfterSpain
-
Iladevi Cataract and IOL Research CenterCompletedCongenital CataractIndia
-
Bausch & Lomb IncorporatedCompleted